| PCEQX | VIVIX | PCEQX / VIVIX | |
| Total Expense Ratio | 1.76 | 0.03 | 5,867% |
| Annual Report Gross Expense Ratio | 1.78 | 0.03 | 5,933% |
| Fund Existence | 31 years | 28 years | - |
| Gain YTD | 13.691 | 15.125 | 91% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 5000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 812M | 254B | 0% |
| Annual Yield % from dividends | 1.21 | 1.86 | 65% |
| Returns for 1 year | 12.36 | 24.28 | 51% |
| Returns for 3 years | -19.36 | 50.26 | -39% |
| Returns for 5 years | -30.43 | 58.89 | -52% |
| Returns for 10 years | -10.95 | 154.95 | -7% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| WPSIX | 50.46 | 0.91 | +1.84% |
| AB Concentrated Growth I | |||
| PABGX | 198.35 | 3.00 | +1.54% |
| T. Rowe Price Blue Chip Growth Advisor | |||
| PCAQX | 92.01 | 0.39 | +0.43% |
| Principal Capital Appreciation R5 | |||
| SAMVX | 13.17 | 0.03 | +0.23% |
| Virtus Ceredex Mid-Cap Value Equity A | |||
| KMDVX | 34.84 | -0.01 | -0.03% |
| Keeley Gabelli Mid Cap Dividend A | |||